Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MANGOCEUTICALS, INC. Director's Dealing 2025

Nov 26, 2025

34879_dirs_2025-11-26_163971e5-9990-4e4f-a739-a6958b3bdc2b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MANGOCEUTICALS, INC. (MGRX)
CIK: 0001938046
Period of Report: 2025-11-19

Reporting Person: Hamilton Alex P. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-11-19 Common Stock S 125000 $1.223 Disposed 3334 Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $1.195 to $1.2465, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.